The Patent Finder

Terms ending in 2030

Actelion Pharmaceuticals Ltd

Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,251,867Dosing Regimen for a Selective S1P1 Receptor Agonist
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 8,288,3856-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-Phenyl-PYRIMIDINES
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 10,660,880Dosing Regimen for a Selective S1P1 Agonist
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 8,809,334Therapeutic Compositions Containing Macitentan
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 8,785,484Dosing Regimen for a Selective S1P1 Receptor Agonist
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 8,658,675PYRIDIN-4-YL Derivatives
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 9,133,1792-Methoxy-PYRIDIN-4-YL-DERIVATIVES
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 8,664,203Thiazole Derivatives and Their Use as P2Y12 Receptor Antagonists
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited